Information Provided By:
Fly News Breaks for August 14, 2019
HOLX
Aug 14, 2019 | 07:53 EDT
Argus analyst David Toung raised his price target on Hologic to $62 and kept his Buy rating after its Q3 earnings beat and "strong" revenue growth that were partially offset by the currency headwinds. The analyst notes that the company's Breast Health and Molecular Diagnostics businesses delivered "strong growth" while it also continued to expand its presence in overseas markets. Toung further anticipates continued solid execution, new product launches, and the integration of recent acquisitions driving "strong performance" in the second half of 2019.
News For HOLX From the Last 2 Days
There are no results for your query HOLX